What is the mechanism of action for antimetabolites in chemotherapy?

What is the mechanism of action for antimetabolites in chemotherapy?

• A. They kill cancer cells directly
• B. They interfere with DNA and RNA synthesis
• C. They block blood flow to tumors
• D. They promote the growth of healthy cells

Answer: (B)

Antimetabolites are a class of chemotherapy agents that function by interfering with the synthesis of DNA and RNA, which are essential for cancer cell proliferation. They are designed to mimic the natural metabolites that cells need to produce nucleic acids. When antimetabolites enter the cell, they are tricked into being incorporated into nucleic acid synthesis processes. This incorporation disrupts the normal formation and function of DNA and RNA, leading to cell cycle arrest and ultimately apoptosis, or programmed cell death. By targeting the specific biochemical pathways that are crucial for cell division and growth, antimetabolites effectively inhibit the cancer cells' ability to multiply and survive. This mechanism is particularly beneficial against rapidly dividing cancer cells, which are often more sensitive to these agents. The other choices do not accurately describe the mechanism of antimetabolites. Killing cancer cells directly is more characteristic of cytotoxic agents that act through different pathways. Blocking blood flow to tumors pertains to anti-angiogenic treatments rather than antimetabolites. Promoting the growth of healthy cells is contrary to the primary action of chemotherapy drugs, which mostly aim to reduce or eliminate cancer cell proliferation.

Antimetabolites are a class of chemotherapy agents that function by interfering with the synthesis of DNA and RNA, which are essential for cancer cell proliferation. They are designed to mimic the natural metabolites that cells need to produce nucleic acids. When antimetabolites enter the cell, they are tricked into being incorporated into nucleic acid synthesis processes. This incorporation disrupts the normal formation and function of DNA and RNA, leading to cell cycle arrest and ultimately apoptosis, or programmed cell death.

By targeting the specific biochemical pathways that are crucial for cell division and growth, antimetabolites effectively inhibit the cancer cells' ability to multiply and survive. This mechanism is particularly beneficial against rapidly dividing cancer cells, which are often more sensitive to these agents.

The other choices do not accurately describe the mechanism of antimetabolites. Killing cancer cells directly is more characteristic of cytotoxic agents that act through different pathways. Blocking blood flow to tumors pertains to anti-angiogenic treatments rather than antimetabolites. Promoting the growth of healthy cells is contrary to the primary action of chemotherapy drugs, which mostly aim to reduce or eliminate cancer cell proliferation.